Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
10% owner at NATR; 10% owner at CONTRAFECT Corp
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Oct 15, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- NATRNATURES SUNSHINE PRODUCTS INC10% owner
- CONTRAFECT Corp10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- CONTRAFECT Corp600,000 shares
- NATR13,195 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CONTRAFECT CorpPlan not statedDec 4, 2018 2018
Sold 600,000 shares at $2.04 ($1.2M)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 10% owner
Sold 7.1% of holdings ($17.3M position)7.9M shares leftFirst sale on recordFiling
- 2 Form 4 sale NATRNo planOct 14, 2024 +2141 days
Sold 10,895 shares at $13.33 ($145k)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 10% owner
No 10b5-1 planSold 14.1% of holdings ($1M position)66,467 shares leftFirst sale on recordFiling
- 3 Form 4 sale NATRNo planOct 15, 2024 +1 day
Sold 2,300 shares at $13.02 ($30k)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 10% owner
No 10b5-1 planSold 3.5% of holdings ($865k position)64,167 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Oct 17, 2024 | NATR | 10% owner | Form 4 sale | 2,300 | $30k | 3.5% | No plan | SEC |
| Oct 14, 2024 | Oct 15, 2024 | NATR | 10% owner | Form 4 sale | 10,895 | $145k | 14.1% | No plan | SEC |
| Dec 4, 2018 | Dec 6, 2018 | CONTRAFECT Corp | 10% owner | Form 4 sale | 600,000 | $1.2M | 7.1% | Plan not stated | SEC |